Matisse Capital Sc Pharmaceuticals Inc. Transaction History

Matisse Capital

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$5.17 - $9.41 $91,431 - $166,415	-17,685 Closed	0 $0
Q2 2020 Jul 28, 2020	SELL	$7.01 - $10.96 $70,100 - $109,600	-10,000 Reduced 36.12%	17,685 $130,000
Q1 2020 May 07, 2020	BUY	$5.4 - $10.45 $70,200 - $135,850	13,000 Added 88.53%	27,685 $205,000
Q3 2019 Oct 28, 2019	BUY	$3.24 - $7.35 $47,579 - $107,934	14,685 New	14,685 $86,000

37.1M

110K

12.1K

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $94.8M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

Get notified when there are updates to the investment portfolio of Matisse Capital, based on Form 13F filings with the SEC.

Stay updated on Matisse Capital with notifications on news.